Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy

• The AIMM Trial Group:,
• Alaa Abouhajar,
• Lisa Alcock,
• Theophile Bigirumurame,
• Penny Bradley,
• Laura Brown,
• Ian Campbell,
• Silvia Del Din,
• Julie Faitg,
• Gavin Falkous,
• Grainne S. Gorman,
• Rachel Lakey,
• Robert McFarland,
• Jane Newman,
• Lynn Rochester,
• Vicky Ryan,
• Hesther Smith,
• Alison Steel,
• Renae J. Stefanetti,
• Huizhong Su,
• Robert W. Taylor,
• Naomi J. P. Thomas,
• Helen Tuppen,
• Amy E. Vincent,
• Charlotte Warren,
• Gillian Watson

Affiliations

The AIMM Trial Group:

Alaa Abouhajar

Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University

Lisa Alcock

Brain and Movement Research Group, Clinical Ageing Research Unit, Translational and Clinical Research Institute, Newcastle University

Theophile Bigirumurame

Population Health Sciences Institute, Newcastle University

Penny Bradley

Pharmacy Directorate, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital

Laura Brown

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Ian Campbell

Pharmacy Directorate, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital

Silvia Del Din

Brain and Movement Research Group, Clinical Ageing Research Unit, Translational and Clinical Research Institute, Newcastle University

Julie Faitg

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Gavin Falkous

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Grainne S. Gorman

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Rachel Lakey

Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University

Robert McFarland

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Jane Newman

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Lynn Rochester

Brain and Movement Research Group, Clinical Ageing Research Unit, Translational and Clinical Research Institute, Newcastle University

Vicky Ryan

Population Health Sciences Institute, Newcastle University

Hesther Smith

Pharmacy Directorate, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital

Alison Steel

Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University

Renae J. Stefanetti

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Huizhong Su

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Robert W. Taylor

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Naomi J. P. Thomas

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Helen Tuppen

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Amy E. Vincent

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Charlotte Warren

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

Gillian Watson

Newcastle Clinical Trials Unit, 1-4 Claremont Terrace, Newcastle University